He joined Leeds Teaching Hospitals in 2002 as a Consultant Immunologist and during his career Phil has worked in many operational and strategic roles including Clinical Director for services such as Pathology and Oncology and Medical Director for Strategy and Planning. He has been a champion and advocate of a continuous improvement approach to healthcare, working with the Virginia Mason Institute over the past decade to help develop the Trust’s improvement system, the Leeds Improvement Method.
Phil has held several regional roles including as Senior Responsible Officer for the initial Covid-19 vaccination programme in West Yorkshire. He is committed to partnership working across health and care systems, and currently co-chairs the West Yorkshire Cancer Alliance. A continued passionate advocate for the role of research and innovation in improving outcomes and reducing inequalities in healthcare, he is Chair of the Northeast & Yorkshire Genomic Medicine Service Board, a member of the NHS England National Genomics Board and a director and board member at the Northern Health Science Alliance.
An Honorary Professorship in Healthcare Leadership from the University of Leeds was awarded in November 2022, recognising Phil’s leadership contribution across education and training, research, innovation and improvement. He is the chair of the Leeds Academic Health Partnership and a member of the NHS IMPACT National Improvement Board.
Read more about the role of Chief Executive and the responsibilities involved (15kB)